"10.1371_journal.pone.0034207","plos one","2012-03-28T00:00:00Z","Eva Källberg; Thomas Vogl; David Liberg; Anders Olsson; Per Björk; Pernilla Wikström; Anders Bergh; Johannes Roth; Fredrik Ivars; Tomas Leanderson","Immunology Group, Lund University, Lund, Sweden; Institute of Immunology, University of Münster, Münster, Germany; Active Biotech AB, Lund, Sweden; Department of Medical Bioscience, Umeå University, Umeå, Sweden","Conceived and designed the experiments: TL TV FI DL JR AB. Performed the experiments: EK PW AO TV PB. Analyzed the data: PB EK TV PW AB JR TL DL AO FI. Contributed reagents/materials/analysis tools: TV PW AB JR PB. Wrote the paper: TL FI DL TV JR.","The authors have read the journals policy and have the following conflicts: TL is a part time employee and DL, AO and PB are full time employees of Active Biotech that develops ABR-215050 for the treatment of prostate cancer. FI has a research grant from Active Biotech. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Eva Källberg","EK",10,TRUE,6,5,10,5,TRUE,TRUE,FALSE,0,NA,FALSE
